-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $492

Benzinga·07/13/2026 14:17:27
Listen to the news
Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $391 to $492.